7th Eurasian Hematology Oncology Summit

 

7th Eurasian Hematology Oncology Summit
R

Management of Ph+ Leukemia During COVID-19 Pandemic: Is Induction / Consolidation Dasatinib + Blinatumomab the Optimal Solution?

By 7th Eurasian Hematology Oncology Summit FEATURING Robin Foa
By 7th Eurasian Hematology Oncology Summit FEATURING Robin Foa
6 views
December 15, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
COVID-19
19:08
7th Eurasian Hematology Oncology Summit

Management of Ph+ Leukemia During COVID-19 Pandemic: Is Induction / …

Feat. R. Foa
17:27
7th Eurasian Hematology Oncology Summit

How SARS-CoV-2 Affects Cancer Patients: Epidemiology, Behavior, Symp…

Feat. R. Chemaly
16:36
7th Eurasian Hematology Oncology Summit

CLL Management During the COVID-19 Pandemic: New Strategies and Cons…

Feat. R. Foa